BioMarin Pharmaceutical Inc. (BMRN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
80.96-1.18 (-1.44%)
At close: 4:00 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close82.14
Bid0.00 x
Ask0.00 x
Day's Range80.56 - 82.28
52wk Range62.12 - 118.48
1y Target EstN/A
Market Cap13.83B
P/E Ratio (ttm)-24.63
Avg Vol (3m)1,487,504
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Ligand Partner Melinta Therapeutics Submits NDA for Baxdela
    Zacks11 hours ago

    Ligand Partner Melinta Therapeutics Submits NDA for Baxdela

    Ligand Pharmaceuticals Incorporated (LGND) said its partner Melinta Therapeutics, a private pharma company, has submitted New Drug Applications (NDAs) to the FDA for its pipeline candidate Baxdela (delafloxacin) to treat serious bacterial infections.

  • Zacks2 days ago

    Merck Gets FDA Approval for Investigational Drug Zinplava

    Merck & Co., Inc. (MRK) announced that the FDA has approved its pipeline candidate Zinplava (bezlotoxumab) for the prevention of Clostridium difficile recurrence.

  • 24/7 Wall St.3 days ago

    Top Health Care Earnings Coming Next Week

    Earnings season is now in full swing, and we have put together a preview of Bristol-Myers, AbbVie and some of the other top players in the health care sector.